Basilea Pharmaceutica AG BPMUF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.79% | -9.40% | |||
| Total Other Revenue | -0.79% | 10.68% | |||
| Total Revenue | -0.79% | -5.56% | |||
| Cost of Revenue | -0.79% | -14.40% | |||
| Gross Profit | -0.79% | 10.44% | |||
| SG&A Expenses | -0.79% | 0.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.79% | -11.83% | |||
| Operating Income | -0.79% | 17.08% | |||
| Income Before Tax | -0.79% | 23.50% | |||
| Income Tax Expenses | -0.79% | 104.62% | |||
| Earnings from Continuing Operations | -0.79% | 16.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.79% | 16.55% | |||
| EBIT | -0.79% | 17.08% | |||
| EBITDA | -0.79% | 9.77% | |||
| EPS Basic | -0.79% | 15.32% | |||
| Normalized Basic EPS | -0.80% | 22.97% | |||
| EPS Diluted | -0.79% | 14.67% | |||
| Normalized Diluted EPS | -0.79% | 21.67% | |||
| Average Basic Shares Outstanding | 0.00% | 1.06% | |||
| Average Diluted Shares Outstanding | 0.00% | 2.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||